Skip to main content
Fig. 2 | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Fig. 2

From: Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis

Fig. 2

Line chart depicts the result of mixed-model repeated-measures analysis of ADHD symptom severity. †ATX atomoxetine, OROS-MPH osmotic-release oral delivery system methylphenidate, T-DSM-IV-S the Turgay DSM-IV disruptive behavior disorders rating scale, AIC Akaike information criterion. a Is total score, b is inattention score, and c is hyperactivity/impulsivity score

Back to article page